Trends in the Incidence of Acute Hepatitis B in the Polish Population and Their Determinants
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Madihi, S.; Syed, H.; Lazar, F.; Zyad, A.; Benani, A. A systematic review of the current hepatitis B viral infection and hepatocellular carcinoma situation in Mediterranean countries. BioMed Res. Int. 2020, 2020, 1–16. [Google Scholar] [CrossRef]
- Pettersson, J.H.-O.; Myking, S.; Elshaug, H.; Bygdås, K.I.E.; Stene-Johansen, K. Molecular epidemiology of hepatitis B virus infection in Norway. BMC Infect. Dis. 2019, 19, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jefferies, M.; Rauff, B.; Rashid, H.; Lam, T.; Rafiq, S. Update on global epidemiology of viral hepatitis and preventive strategies. World J. Clin. Cases 2018, 6, 589. [Google Scholar] [CrossRef] [PubMed]
- Nayagam, S.; Thursz, M. Strategies for global elimination of chronic HBV infection: 2019 update. Curr. Hepatol. Rep. 2019, 18, 300–309. [Google Scholar] [CrossRef] [Green Version]
- Hyun Kim, B.; Ray Kim, W. Epidemiology of hepatitis B virus infection in the United States. Clin. Liver Dis. 2018, 12, 1–4. [Google Scholar] [CrossRef] [PubMed]
- Wiktor, A.; Borawski, T.; Stępień, M. Hepatitis B in Poland in 2017. Przegląd Epidemiol. 2019, 73, 157–166. [Google Scholar] [CrossRef]
- Wiktor, A.; Stępień, M. Hepatitis B in Poland in 2018. Przegląd Epidemiol. 2020, 74, 196–208. [Google Scholar] [CrossRef] [PubMed]
- European Centre for Disease Prevention and Control. Chronic Hepatitis B Infections on the Rise Since 2008. 2019. Available online: https://www.ecdc.europa.eu/en/news-events/chronic-hepatitis-b-infections-rise-2008 (accessed on 17 May 2021).
- Hepatitis B Annual Epidemiological Report for 2017; European Centre for Disease Prevention and Control: Stockholm, Germany, 2019.
- Global Immunization Coverage 2019. 2019. Available online: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage (accessed on 17 May 2021).
- Waheed, Y.; Siddiq, M.; Jamil, Z.; Najmi, M.H. Hepatitis elimination by 2030: Progress and challenges. World J. Gastroenterol. 2018, 24, 4959–4961. [Google Scholar] [CrossRef]
- Smith, S.; Harmanci, H.; Hutin, Y.; Hess, S.; Bulterys, M.; Peck, R.; Rewari, B.; Mozalevskis, A.; Shibeshi, M.; Mumba, M.; et al. Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017. JHEP Rep. 2019, 1, 81–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Definicje Przypadków Chorób Zakaźnych na Potrzeby Nadzoru Epidemiologicznego. 2021. Available online: http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL1_3.pdf (accessed on 17 May 2021).
- Czarkowski, M.P.; Bobel, D. Wirusowe zapalenia wątroby typu B w 2006 roku. Przegląd Epidemiol. 2008, 62, 317–324. [Google Scholar]
- Duffell, E.F.; van de Laar, M.J. Survey of surveillance systems and select prevention activities for hepatitis B and C, European Union/European Economic Area, 2009. Eurosurveillance 2015, 20, 21080. Available online: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES2015.20.13.21080 (accessed on 17 May 2021). [CrossRef] [Green Version]
- Dakic, Z.; Duric, P.; Fabri, M.; O’May, F. Validity of hepatitis B and hepatitis C case definitions. J. Infect. Public Health 2019, 12, 516–521. [Google Scholar] [CrossRef]
- Magdzik, W.; Czarkowski, M.P. Sytuacja epidemiologiczna wirusowego zapalenia wątroby typu B w Polsce w latach 1979–2004. Przegląd Epidemiol. 2006, 60, 471–480. [Google Scholar]
- Choroby Zakaźne i Zatrucia w Polsce, Biuletyny Roczne z lat 2005–2019; Narodowy Instytut Zdrowia Publicznego—Państwowy Zakład Higieny: Warsaw, Poland, 2020.
- Miglietta, A.; Quinten, C.; Lopalco, P.L.; Duffell, E. Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014. Eurosurveillance 2018, 23, 17-00278. Available online: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.6.17-00278 (accessed on 17 May 2021). [CrossRef]
- Sagnelli, E. Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J. Gastroenterol. 2014, 20, 7635. [Google Scholar] [CrossRef]
- Zanella, B.; Bechini, A.; Boccalini, S.; Sartor, G.; Tiscione, E.; Bonanni, P. Hepatitis B seroprevalence in the pediatric and adolescent population of Florence (Italy): An update 27 years after the implementation of universal vaccination. Vaccines 2020, 8, 156. [Google Scholar] [CrossRef] [Green Version]
- Hepatitis B Annual Epidemiological Report for 2018; European Centre for Disease Prevention and Control: Stockholm, Germany, 2020; Available online: https://www.ecdc.europa.eu/sites/default/files/documents/HEPB_AER_2018_Report.pdf (accessed on 17 May 2021).
- Yim, S.Y.; Kim, J.H. The epidemiology of hepatitis B virus infection in Korea. Korean J. Intern. Med. 2019, 34, 945–953. [Google Scholar] [CrossRef] [PubMed]
- New Zealand Ministry of Health. Hepatitis B in Immunisation Handbook 2020. 2020. Available online: https://www.health.govt.nz/system/files/documents/pages/immunisation-handbook-2020-9-hepatitis-b-sep20-v4.pdf (accessed on 17 May 2021).
- Public Health Agency of Canada. Epi-Update: Brief Report: Hepatitis B Infection in Canada. 2011. Available online: https://central.bac-lac.gc.ca/.item?id=HP40-40-2011-eng&op=pdf&app=Library (accessed on 17 May 2021).
- Hepatitis—United States, 2017; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2019. Available online: https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm (accessed on 17 May 2021).
- Viral Hepatitis Surveillance Report 2019—Introduction; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2021. Available online: https://www.cdc.gov/hepatitis/statistics/2019surveillance/Introduction.htm (accessed on 17 May 2021).
- Rimšelienė, G.; Nilsen, Ø.; Kløvstad, H.; Blystad, H.; Aavitsland, P. Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992–2009. BMC Infect. Dis. 2011, 11, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nelson, N.P.; Easterbrook, P.J.; McMahon, B.J. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin. Liver Dis. 2016, 20, 607–628. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Al-Jubran, K.M.; Al-Dossary, M.A.; Elsafi, S.H. The declining rates of hepatitis B carriage among adolescents and young people in the Eastern region of Saudi Arabia. Saudi Med. J. 2016, 37, 864–870. [Google Scholar] [CrossRef] [PubMed]
- Su, W.J.; Liu, C.C.; Liu, D.P.; Chen, S.F.; Huang, J.J.; Chan, T.C.; Chang, M.H. Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. J. Infect. Dis. 2012, 205, 757–762. [Google Scholar] [CrossRef] [Green Version]
- Hepatitis B Key Facts; World Health Organization: Geneva, Switzerland, 2021; Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (accessed on 17 May 2021).
- Hepatitis B in the WHO European Region; World Health Organization: Geneva, Switzerland, 2019; Available online: https://www.euro.who.int/__data/assets/pdf_file/0007/377251/Fact-Sheet-Hepatitis-B_2019-ENG.pdf (accessed on 17 May 2021).
- Magdzik, W.; Czarkowski, M.P. Stan zaszczepienia przeciwko wirusowemu zapaleniu wątroby typu B w Polsce do końca 2004 roku. Przegląd Epidemiol. 2006, 60, 185–192. [Google Scholar]
- Komunikat Głównego Inspektora Sanitarnego z Dnia 17 Października 2011 r. w Sprawie Programu Szczepień Ochronnych na rok 2011. 2011. Available online: https://sip.lex.pl/akty-prawne/dzienniki-resortowe/program-szczepien-ochronnych-na-rok-2011-34524903 (accessed on 17 May 2021).
- Komunikat Głównego Inspektora Sanitarnego z Dnia 25 Października 2018 r. w Sprawie Programu Szczepień Ochronnychnarok 2019. 2018. Available online: http://dziennikmz.mz.gov.pl/legalact/2018/104/ (accessed on 17 May 2021).
- Nitsch-Osuch, A.; Pawlus, B.; Pawlak, M.; Kuchar, E. Decreasing Vaccination Coverage Against Hepatitis B and Tuberculosis in Newborns. Trends Biomed. Res. 2019, 99–105. Available online: http://link.springer.com/10.1007/5584_2019_446 (accessed on 17 May 2021).
- European Centre for Disease Prevention and Control. Monitoring the Responses to Hepatitis B and C Epidemics in EU/EEA Member States, 2019; European Centre for Disease Prevention and Control: Stockholm, Germany, 2020; Available online: https://data.europa.eu/doi/10.2900/034039 (accessed on 17 May 2021).
- World Health Organization. European Vaccine Action Plan 2015–2020 Midterm Report; World Health Organization: Copenhagen, Danmark, 2018; Available online: https://www.euro.who.int/__data/assets/pdf_file/0007/381184/evap-midterm-report-eng.pdf (accessed on 17 May 2021).
- Narodowy Instytut Zdrowia Publicznego Państwowy Zakład Higieny. Profilaktyka Wirusowego Zapalenia Wątroby Typu B i C. 2021. Available online: https://watrobanieboli.pzh.gov.pl/profilaktyka-wirusowego-zapalenia-watroby-typu-b-i-c/ (accessed on 17 May 2021).
- Pawłowska, M.; Sobolewska-Pilarczyk, M. Rekomendacje postępowania w profilaktyce wertykalnych zakażeń HBV i HCV. Przegląd Epidemiol. 2016, 70, 119–120. [Google Scholar]
- Lieshout-Krikke, R.W.; Domanovic, D.; de Kort, W.; Mayr, W.; Liumbruno, G.M.; Pupella, S.; Kurz, J.; Knutson, F.; MacLennan, S.; Folléa, G. Selection strategies for newly registered blood donors in European countries. Blood Transfus. 2017, 15, 495. [Google Scholar] [CrossRef] [PubMed]
- Hepatitis B and C Testing in the EU/EEA: Progress in Reaching the Elimination Targets; European Centre for Disease Prevention and Control: Stockholm, Germany, 2021.
Crude Rates Comparison | Comparison of the Exponential Time Trends | |||||
---|---|---|---|---|---|---|
Crude Rate | p-Value | Slope Coefficient | p-Value | Pearson’s Correlation Coefficient | p-Value | |
Female | 0.32 | <0.0001 | −0.21 | 0.4357 | −0.97 | 0.4537 |
Male | 0.62 | −0.19 | −0.95 | |||
City | 0.52 | <0.001 | −0.19 | 0.1574 | −0.95 | 0.9764 |
Village | 0.39 | −0.23 | −0.95 |
Age Groups | n | Pearson’s Correlation Coefficient | Slope Coefficient | p-Value Benajamini Corected |
---|---|---|---|---|
0–4 | 6 | −0.50 | −6.68 | 0.3912 |
5–9 | 3 | NA | Too few infected | |
10–14 | 19 | −0.91 | −3.50 | 0.1010 |
15–19 | 54 | −0.72 | −2.59 | 0.0224 |
20–24 | 204 | −0.92 | −2.89 | 0.0002 |
25–29 | 298 | −0.90 | −2.89 | 0.0000 |
30–34 | 254 | −0.91 | −5.80 | 0.0000 |
35–39 | 236 | −0.77 | −3.48 | 0.0010 |
40–44 | 190 | −0.92 | −4.51 | 0.0000 |
45–49 | 217 | −0.88 | −5.08 | 0.0000 |
50–54 | 220 | −0.82 | −3.40 | 0.0003 |
55–59 | 204 | −0.94 | −3.65 | 0.0000 |
60–64 | 183 | −0.88 | −3.23 | 0.0000 |
65–74 | 331 | −0.96 | −4.01 | 0.0000 |
75+ | 268 | −0.86 | −3.29 | 0.0001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Stawinska-Witoszynska, B.; Klos, J.; Moryson, W.; Wieckowska, B. Trends in the Incidence of Acute Hepatitis B in the Polish Population and Their Determinants. Medicina 2021, 57, 738. https://doi.org/10.3390/medicina57080738
Stawinska-Witoszynska B, Klos J, Moryson W, Wieckowska B. Trends in the Incidence of Acute Hepatitis B in the Polish Population and Their Determinants. Medicina. 2021; 57(8):738. https://doi.org/10.3390/medicina57080738
Chicago/Turabian StyleStawinska-Witoszynska, Barbara, Jan Klos, Waclaw Moryson, and Barbara Wieckowska. 2021. "Trends in the Incidence of Acute Hepatitis B in the Polish Population and Their Determinants" Medicina 57, no. 8: 738. https://doi.org/10.3390/medicina57080738